Discovery and biological evaluation of new selective acetylcholinesterase inhibitors with anti-Aβ aggregation activity through molecular docking-based virtual screening
release_2vcfcrp7qzesvgtw7k7rwuunpy
by
Guangpu Liu, Yang Jiao, Yongqiang Lin, Haifang Hao, Yanli Dou, Juan Yang, Cheng-Shi Jiang, Ping Chang
2019 Volume 68, Issue 2, p161-166
Abstract
Discovery of novel multifunctional inhibitors targeting acetylcholinesterase (AChE) has becoming a hot spot in anti-Alzheimer's disease (AD) drug development. In the present study, four potent small molecule inhibitors (A01, A02, A03 and A04) of AChE with new chemical scaffold were identified. Inhibitor A03 displayed the most potent inhibition activity on AChE at enzymatic level with IC50 value of 180 nM, and high selectivity towards AChE over butyrylcholinesterase (BChE) by more than 100-fold. The binding modes of compounds A01-A04 were carefully analyzed by molecular docking and molecular dynamics (MD) simulation to provide informative clues for further structure modification. Finally, the anti-amyloid beta (Aβ) aggregation and neuroprotective activity were also well investigated. Our findings highlighted the therapeutic promise of AChE inhibitors A01-A04 for AD treatment.
In text/plain
format
Archived Files and Locations
application/pdf 2.1 MB
file_bgtu5hjnmvhzzmdnzld5oojypy
|
www.jstage.jst.go.jp (repository) web.archive.org (webarchive) |
access all versions, variants, and formats of this works (eg, pre-prints)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar